The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019

Progression to severe disease is a difficult problem in treating coronavirus disease 2019 (COVID‐19). The purpose of this study is to explore changes in markers of severe disease in COVID‐19 patients. Sixty‐nine severe COVID‐19 patients were included. Patients with severe disease showed significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tao, Zhang, Jieying, Yang, Yuhui, Ma, Hong, Li, Zhenyu, Zhang, Jiaoyue, Cheng, Ji, Zhang, Xiaoyun, Zhao, Yanxia, Xia, Zihan, Zhang, Liling, Wu, Gang, Yi, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280589/
https://www.ncbi.nlm.nih.gov/pubmed/32428990
http://dx.doi.org/10.15252/emmm.202012421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280589/
https://www.ncbi.nlm.nih.gov/pubmed/32428990
http://dx.doi.org/10.15252/emmm.202012421

Ejemplares similares